Literature DB >> 19892554

Synthesis and structure-activity relationships of cassiarin A as potential antimalarials with vasorelaxant activity.

Hiroshi Morita1, Yuichiro Tomizawa, Jun Deguchi, Tokio Ishikawa, Hiroko Arai, Kazumasa Zaima, Takahiro Hosoya, Yusuke Hirasawa, Takayuki Matsumoto, Katsuo Kamata, Wiwied Ekasari, Aty Widyawaruyanti, Tutik Sri Wahyuni, Noor Cholies Zaini, Toshio Honda.   

Abstract

Cassiarin A 1, a tricyclic alkaloid, isolated from the leaves of Cassia siamea (Leguminosae), shows powerful antimalarial activity against Plasmodium falciparum in vitro as well as P. berghei in vivo, which may be valuable leads for novel antimalarials. Interactions of parasitized red blood cells (pRBCs) with endothelium in aorta are especially important in the processes contribute to the pathogenesis of severe malaria. Nitric oxide (NO) reduces endothelial expression of receptors/adhesion molecules used by pRBC to adhere to vascular endothelium, and reduces cytoadherence of pRBC to vascular endothelium. Cassiarin A 1 showed vasorelaxation activity against rat aortic ring, which may be related with NO production. A series of a hydroxyl and a nitrogen-substituted derivatives and a dehydroxy derivative of 1 have been synthesized as having potent antimalarials against P. falciparum with vasodilator activity, which may reduce cytoadherence of pRBC to vascular endothelium. Cassiarin A 1 exhibited a potent antimalarial activity and a high selectivity index in vitro, suggesting that the presence of a hydroxyl and a nitrogen atom without any substituents may be important to show antimalarial activity. Relative to cassiarin A, a methoxy derivative showed more potent vasorelaxant activity, although it did not show improvement for inhibition of P. falciparum in vitro. These cassiarin derivatives may be promising candidates as antimalarials with different mode of actions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19892554     DOI: 10.1016/j.bmc.2009.10.013

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  7 in total

1.  Vasorelaxant effect of FR900359 from Ardisia crenata on rat aortic artery.

Authors:  Kazumasa Zaima; Jun Deguchi; Yosuke Matsuno; Toshio Kaneda; Yusuke Hirasawa; Hiroshi Morita
Journal:  J Nat Med       Date:  2012-03-03       Impact factor: 2.343

2.  Vasorelaxant effect of isoquinoline derivatives from two species of Popowia perakensis and Phaeanthus crassipetalus on rat aortic artery.

Authors:  Kazumasa Zaima; Yuka Takeyama; Ikumi Koga; Aiko Saito; Haruka Tamamoto; Saripah Salbiah Syed Abd Azziz; Mat Ropi Mukhtar; Khalijah Awang; A Hamid A Hadi; Hiroshi Morita
Journal:  J Nat Med       Date:  2011-10-28       Impact factor: 2.343

3.  Concise synthesis of 5-methoxy-6-hydroxy-2-methylchromone-7-O- and 5-hydroxy-2-methylchromone-7-O-rutinosides. Investigation of their cytotoxic activities against several human tumor cell lines.

Authors:  Baolin Wu; Wenpeng Zhang; Zhonghua Li; Li Gu; Xin Wang; Peng George Wang
Journal:  J Org Chem       Date:  2011-03-02       Impact factor: 4.354

4.  Vasorelaxant activity of indole alkaloids from Tabernaemontana dichotoma.

Authors:  Kazumasa Zaima; Ikumi Koga; Nobuhide Iwasawa; Takahiro Hosoya; Yusuke Hirasawa; Toshio Kaneda; Intan Safinar Ismail; Nordin Hj Lajis; Hiroshi Morita
Journal:  J Nat Med       Date:  2012-02-21       Impact factor: 2.343

5.  Antimalarial Natural Products.

Authors:  David G I Kingston; Maria Belen Cassera
Journal:  Prog Chem Org Nat Prod       Date:  2022

6.  Inverse docking based screening and identification of protein targets for Cassiarin alkaloids against Plasmodium falciparum.

Authors:  Arvind Negi; Nitisha Bhandari; Bharti Rajesh Kumar Shyamlal; Sandeep Chaudhary
Journal:  Saudi Pharm J       Date:  2018-02-02       Impact factor: 4.330

7.  First total synthesis of ampullosine, a unique isoquinoline alkaloid isolated from Sepedonium ampullosporum, and of the related permethylampullosine.

Authors:  Didier F Vargas; Enrique L Larghi; Teodoro S Kaufman
Journal:  RSC Adv       Date:  2019-10-16       Impact factor: 4.036

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.